Clinical Trial Update: Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC [Phase 2]

View source ↗

Summary

Phase 2 study evaluating hepatic arterial infusion of cisplatin and fluorouracil in biomarker-stratified hepatocellular carcinoma. The current trial status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: CbsBioscience | Conditions: Hepatocellular Carcinoma Non-Resectable | Phase 2 | Status: UNKNOWN